Pharmacological therapy for stable chronic obstructive pulmonary disease

In recent years, emphasis has shifted from preventing and treating chronic obstructive pulmonary disease (COPD) to early prevention, early treatment, and disease stabilization, with the main goal of improving patients’ quality of life and reducing the frequency of acute exacerbations. This review su...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Ruirui, Li, Baicun, Yang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249181/
https://www.ncbi.nlm.nih.gov/pubmed/37305108
http://dx.doi.org/10.1002/cdt3.65
_version_ 1785055505936285696
author Duan, Ruirui
Li, Baicun
Yang, Ting
author_facet Duan, Ruirui
Li, Baicun
Yang, Ting
author_sort Duan, Ruirui
collection PubMed
description In recent years, emphasis has shifted from preventing and treating chronic obstructive pulmonary disease (COPD) to early prevention, early treatment, and disease stabilization, with the main goal of improving patients’ quality of life and reducing the frequency of acute exacerbations. This review summarizes pharmacological therapies for stable COPD.
format Online
Article
Text
id pubmed-10249181
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102491812023-06-09 Pharmacological therapy for stable chronic obstructive pulmonary disease Duan, Ruirui Li, Baicun Yang, Ting Chronic Dis Transl Med Reviews In recent years, emphasis has shifted from preventing and treating chronic obstructive pulmonary disease (COPD) to early prevention, early treatment, and disease stabilization, with the main goal of improving patients’ quality of life and reducing the frequency of acute exacerbations. This review summarizes pharmacological therapies for stable COPD. John Wiley and Sons Inc. 2023-04-05 /pmc/articles/PMC10249181/ /pubmed/37305108 http://dx.doi.org/10.1002/cdt3.65 Text en © 2023 The Authors. Chronic Diseases and Translational Medicine published by John Wiley & Sons, Ltd on behalf of Chinese Medical Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Reviews
Duan, Ruirui
Li, Baicun
Yang, Ting
Pharmacological therapy for stable chronic obstructive pulmonary disease
title Pharmacological therapy for stable chronic obstructive pulmonary disease
title_full Pharmacological therapy for stable chronic obstructive pulmonary disease
title_fullStr Pharmacological therapy for stable chronic obstructive pulmonary disease
title_full_unstemmed Pharmacological therapy for stable chronic obstructive pulmonary disease
title_short Pharmacological therapy for stable chronic obstructive pulmonary disease
title_sort pharmacological therapy for stable chronic obstructive pulmonary disease
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249181/
https://www.ncbi.nlm.nih.gov/pubmed/37305108
http://dx.doi.org/10.1002/cdt3.65
work_keys_str_mv AT duanruirui pharmacologicaltherapyforstablechronicobstructivepulmonarydisease
AT libaicun pharmacologicaltherapyforstablechronicobstructivepulmonarydisease
AT yangting pharmacologicaltherapyforstablechronicobstructivepulmonarydisease

Ejemplares similares